Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

smithkline beecham animal health - sodium selenate | clostridium chauvoei - killed | clostridium chauvoei - toxoid | clostridium novyi type b - toxoid | clostridium perfringens type d toxoid | clostridium septicum - toxoid | clostridium tetani - toxoid - immunotherapy - lamb | ovine - not applicable (vet)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - hydroxocobalamin acetate; moxidectin; selenium as sodium selenate; blackleg = clostridium chauvoei; enterotoxaemia = pulpy kidney = c perfringens; clostridium novyi type b; malignant oedema = clostridium septicum; tetanus = clostridium tetani; corynebacterium pseudotuberculosis (ovis) - toxoid; thiomersal - misc. vaccines or anti sera - hydroxocobalamin acetate vitamin-b12 active 1.0 mg/ml; moxidectin anthelmintic active 5.0 mg/ml; selenium as sodium selenate mineral-selenium active 1.0 mg/ml; blackleg = clostridium chauvoei vaccine-microbial active 0.0 p; enterotoxaemia = pulpy kidney = c perfringens vaccine-microbial active 0.0 p; clostridium novyi type b vaccine-microbial active 0.0 p; malignant oedema = clostridium septicum vaccine-microbial active 0.0 p; tetanus = clostridium tetani vaccine-toxoid active 0.0 p; corynebacterium pseudotuberculosis (ovis) - toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.13 mg/ml - immuno+parasite+nutrition - sheep - not lambs | ewe | ovine | ram - barber's pole worm-haemonchus contortus | black disease | blackleg | brown stomach worm - ostertagia lyrata | caseous lymphadenitis (cheesy gland) | cooperia curticei | cooperia oncophora | enterotoxaemia (pulpy kidney) | intestinal hair worm - t. colubriformis | intestinal threadworm - s. papillosus | large bowel worm - o. venulosum | large lungworm - adult & l4 stages | large lungworm - dictyocaulus filaria | large mouth bowel worm - chabertia spp. | large mouthed bowel worm | malignant oedema | nasal bot | nematodirus abnormalis | nematodirus battus | nematodirus filicollis | nematodirus helvetianus | nodule worm - o. columbianum | ostertagia circumcincta | ostertagia trifurcata | selenium responsive condition | sheep itch mite | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | stomach hair worm | tetanus | thin necked intestinal worm | thin necked intestinal worm-n. spathiger | trichostrongylus rugatus | trichostrongylus spp. - adult/4th stage | vitamin b12 deficiency | w

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

csl limited - selenium as sodium selenate | blackleg = clostridium chauvoei | enterotoxaemia = pulpy kidney = c perfringens | malignant oedema = clostridium septicum | cla = corynebacterium pseudotuberculosis ovis | clostridium novyi type b - toxoid | tetanus = clostridium tetani - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - black disease | blackleg | cheesy gland | enterotoxaemia (pulpy kidney) | malignant oedema | selenium deficiency | tetanus | clostridium perfringens type d | lymphadenitis | lymphangitis | tetanus vaccination | white muscle disease

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

websters - corynebacterium pseudotubercul+cl perfringens toxoid (d) + others - parenteral liquid/solution/suspension - vaccine - lamb | ovine - black disease | blackleg | cheesy gland | enterotoxaemia (pulpy kidney) | malignant oedema | selenium deficiency | tetanus | unthriftiness | white muscle disease | clostridium perfringens type d | ill - thrift | lymphadenitis | lymphangitis | selenium deficiency | selenium responsive ill-thrift | stiff lamb disease | subacute enzootic muscular dys | tetanus vaccination | white muscle disease

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - clostridium difficile (unii: pjx89v9r6n) (clostridium difficile - unii:pjx89v9r6n) - clostridium difficile 15 [hp_x] in 1 ml - for temporary relief of symptoms related to clostridium difficile which include occasional diarrhea, intestinal cramping and fevers.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to clostridium difficile which include occasional diarrhea, intestinal cramping and fevers.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - clostridium difficile (unii: pjx89v9r6n) (clostridium difficile - unii:pjx89v9r6n) - clostridium difficile 15 [hp_x] in 1 ml - for temporary relief of symptoms related to clostridium difficile which include uncontrollable diarrhea, intestinal cramping and fevers.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to clostridium difficile which include uncontrollable diarrhea, intestinal cramping and fevers.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - clostridium perfringens type d toxoid; clostridium septicum toxoid; clostridium novyi type b toxoid/cells; clostridium chauvoei toxoid/cells; clostridium tetani toxoid; selenium - clostridium perfringens type d toxoid 0 vaccine; clostridium septicum toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium tetani toxoid 0 vaccine; selenium 5 g/litre - vaccine

United States - English - NLM (National Library of Medicine)

rebel distributors - clostridium tetani (unii: 751e8j54vm) (clostridium tetani - unii:751e8j54vm), corynebacterium diphtheriae (unii: 3u7e3o07s8) (corynebacterium diphtheriae - unii:3u7e3o07s8) - clostridium tetani 2.0 in 0.5 ml - massbiologics' td is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria.  this vaccine is approved for use in persons 7 years of age and older. a severe allergic reaction (e.g., anaphylaxis) occurring after a previous dose of this vaccine, or any other tetanus or diphtheria toxoid-containing vaccine, or any component of this vaccine is a contraindication to administration of massbiologics' td vaccine.  (see description ).  because of the uncertainty as to which component of the vaccine might be responsible, no further vaccination with diphtheria or tetanus components should be carried out.  alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered.

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h) - clostridium tetani toxoid antigen (formaldehyde inactivated) 5 [lf] in 0.5 ml - tenivac® is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older. a severe allergic reaction (e.g., anaphylaxis) after a previous dose of tenivac or any other tetanus toxoid or diphtheria toxoid-containing vaccine or any other component of this vaccine is a contraindication to administration of tenivac. [see description (11) .] because of uncertainty as to which component of the vaccine may be responsible, none of the components should be administered. alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. there are no adequate and well-controlled studies of tenivac administration in pregnant women in t

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h), bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (unii: f4tn0ipy37) (bordetella pertussis toxoid antigen (glutaraldehyde inactivated) - unii:f4tn0ipy37 - clostridium tetani toxoid antigen (formaldehyde inactivated) 5 [lf] in 0.5 ml - adacel® is a vaccine indicated for: - active booster immunization against tetanus, diphtheria and pertussis. adacel is approved for use in individuals 10 through 64 years of age. immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age. a severe allergic reaction (e.g., anaphylaxis) after a previous dose of any tetanus toxoid, diphtheria toxoid or pertussis containing vaccine or any other component of this vaccine is a contraindication to administration of adacel. [see description (11). ] because of uncertainty as to which component of the vaccine may be responsible, none of the components should be administered. alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered. encephalopathy (e.g., coma, prolonged seizures, or decreased level of consciousness) within 7 days of a previous dose of a pertussis containing vaccine not attributable to another identifiable cause is a contraindicatio